Palisade Bio, Inc. (PALI)
1.95
-0.06
(-2.99%)
USD |
NASDAQ |
May 22, 16:00
1.94
-0.01
(-0.51%)
After-Hours: 20:00
Palisade Bio EPS Diluted (Quarterly) : -0.0458 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 0.1889 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Savara, Inc. | -0.1472 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.60M |
| Total Expenses (Quarterly) | 9.60M |
| Enterprise Value | 206.24M |
| Earnings Yield | -54.65% |
| Normalized Earnings Yield | -56.20 |